IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Johnson & Johnson

Q3 2026 Holdings

Filed 2026-10-26 | 15 holdings | $761.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Protagonist Therapeutics Inc(PTGX)COM74366E102$345.1M2,449,18345.3%
Nanobiotix(NBTX)SPONSORED ADS63009J107$175.2M5,623,81623.0%
Meiragtx Hldgs PLC(MGTX)COMG59665102$73.1M6,641,0649.6%
Rapport Therapeutics Inc(RAPP)COM75383L102$60.0M1,784,5177.9%
Contineum Therapeutics Inc(CTNM)CL A21217B100$26.6M1,979,1733.5%
Cerebras Systems Inc(CBRS)COM CL A15675D103$22.9M128,6493.0%
Xencor Inc(XNCR)COM98401F105$18.7M748,0622.5%
Legend Biotech Corp(LEGN)SPONSORED ADS52490G102$16.2M814,5862.1%
Fate Therapeutics Inc(FATE)COM31189P102$8.0M3,379,0641.1%
Cvrx Inc(CVRX)COM126638105$7.0M4,024,8610.9%
Procept Biorobotics Corp(PRCT)COM74276L105$6.5M357,9390.9%
Neumora Therapeutics Inc.(NMRA)COM640979100$1.1M1,849,4450.1%
VOR Biopharma Inc(VOR)COM NEW929033207$1.0M53,7320.1%
Standard Biotools Inc(LAB)COM34385P108$231.0K311,9670.0%
Adicet BIO Inc(ACET)COM NEW007002207$162.6K22,7790.0%